Bortolotti F - Search Results

1

Highly selective fluorescent analogue of the potent delta-opioid receptor antagonist Dmt-Tic.

Balboni G, Salvadori S, Dal Piaz A, Bortolotti F, Argazzi R, Negri L, Lattanzi R, Bryant SD, Jinsmaa Y, Lazarus LH. Balboni G, et al. Among authors: bortolotti f. J Med Chem. 2004 Dec 16;47(26):6541-6. doi: 10.1021/jm040128h. J Med Chem. 2004. PMID: 15588089

2

Symmetry-based inhibitors of HIV-1 protease. Design, synthesis and preliminary structure-activity studies of acylated 2,3-diamino-1-hydroxypropanes and 2,4 diamino-1-hydroxybutanes.

Marastoni M, Bazzaro M, Bortolotti F, Salvadori S, Tomatis R. Marastoni M, et al. Among authors: bortolotti f. Eur J Med Chem. 1999 Jul-Aug;34(7-8):651-7. doi: 10.1016/s0223-5234(00)80034-3. Eur J Med Chem. 1999. PMID: 11278050

3

Design, synthesis and in vitro evaluation on HRPE cells of ascorbic and 6-bromoascorbic acid conjugates with neuroactive molecules.

Manfredini S, Vertuani S, Pavan B, Vitali F, Scaglianti M, Bortolotti F, Biondi C, Scatturin A, Prasad P, Dalpiaz A. Manfredini S, et al. Among authors: bortolotti f. Bioorg Med Chem. 2004 Oct 15;12(20):5453-63. doi: 10.1016/j.bmc.2004.07.043. Bioorg Med Chem. 2004. PMID: 15388172

4

HIV-1 protease inhibitors containing an N-hydroxyamino acid core structure.

Marastoni M, Bazzaro M, Salvadori S, Bortolotti F, Tomatis R. Marastoni M, et al. Among authors: bortolotti f. Bioorg Med Chem. 2001 Apr;9(4):939-45. doi: 10.1016/s0968-0896(00)00308-4. Bioorg Med Chem. 2001. PMID: 11354677

5

A novel conjugated agent between dopamine and an A2A adenosine receptor antagonist as a potential anti-Parkinson multitarget approach.

Dalpiaz A, Cacciari B, Vicentini CB, Bortolotti F, Spalluto G, Federico S, Pavan B, Vincenzi F, Borea PA, Varani K. Dalpiaz A, et al. Among authors: bortolotti f. Mol Pharm. 2012 Mar 5;9(3):591-604. doi: 10.1021/mp200489d. Epub 2012 Feb 9. Mol Pharm. 2012. PMID: 22292533

6

Synthesis and study of 5'-ester prodrugs of N6-cyclopentyladenosine, a selective A1 receptor agonist.

Dalpiaz A, Scatturin A, Menegatti E, Bortolotti F, Pavan B, Biondi C, Durini E, Manfredini S. Dalpiaz A, et al. Among authors: bortolotti f. Pharm Res. 2001 Apr;18(4):531-6. doi: 10.1023/a:1011018730459. Pharm Res. 2001. PMID: 11451042

7

Structure-activity relationships of HIV-1 protease inhibitors containing gem-diaminoserine core unit.

Marastoni M, Bortolotti F, Salvadori S, Tomatis R. Marastoni M, et al. Among authors: bortolotti f. Arzneimittelforschung. 1998 Jun;48(6):709-12. Arzneimittelforschung. 1998. PMID: 9689433

8

Preparation and characterization of starch/cyclodextrin bioadhesive microspheres as platform for nasal administration of Gabexate Mesylate (Foy) in allergic rhinitis treatment.

Fundueanu G, Constantin M, Dalpiaz A, Bortolotti F, Cortesi R, Ascenzi P, Menegatti E. Fundueanu G, et al. Among authors: bortolotti f. Biomaterials. 2004 Jan;25(1):159-70. doi: 10.1016/s0142-9612(03)00477-0. Biomaterials. 2004. PMID: 14580919

9

HIV-1 protease inhibitors containing a novel C2 symmetrical hydroxyalkylgem-diamino core structure.

Marastoni M, Salvadori S, Bortolotti F, Tomatis R. Marastoni M, et al. Among authors: bortolotti f. J Pept Res. 1997 Jun;49(6):538-44. doi: 10.1111/j.1399-3011.1997.tb01161.x. J Pept Res. 1997. PMID: 9266481

10

Caffeine intake induces an alteration in human neutrophil A2A adenosine receptors.

Varani K, Portaluppi F, Gessi S, Merighi S, Vincenzi F, Cattabriga E, Dalpiaz A, Bortolotti F, Belardinelli L, Borea PA. Varani K, et al. Among authors: bortolotti f. Cell Mol Life Sci. 2005 Oct;62(19-20):2350-8. doi: 10.1007/s00018-005-5312-z. Cell Mol Life Sci. 2005. PMID: 16143823 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

334 results

Search Page

Filters